Consistent with emerging evidence, syndecan-4 emerges as a critical mediator of ECM-integrin interplay, facilitating focal adhesion kinase activation and cytoskeletal remodeling that promote tumor invasiveness (47). Here, SDC4 is linked to neoplasm.